Loading...
Header Logo
Keywords
Last Name
Institution

HERBERT DUPONT

TitleClinical Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
DivisionMedicine-Infectious Disease
vCardDownload vCard
    Other Positions
    TitleAdjunct Professor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Molecular Virology & Microbiology
    DivisionMolecular Virology & Microbiology


    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Research 
    Collapse research activities and funding
    R01AI023049     (DUPONT, HERBERT L)Apr 1, 1986 - Nov 30, 1990
    NIH/NIAID
    US/MEXICAN STUDENTS SUSCEPTIBILITY TO ENTERIC PATHOGENS
    Role: Principal Investigator

    R55AI031356     (DUPONT, HERBERT L)Sep 30, 1991 - Feb 29, 1992
    NIH/NIAID
    HIV-ASSOCIATED DIARRHEA AND WASTING IN ZAMBIA
    Role: Principal Investigator

    R01AI031356     (DUPONT, HERBERT L)Sep 30, 1991 - Feb 28, 1997
    NIH/NIAID
    HIV-ASSOCIATED DIARRHEA AND WASTING IN ZAMBIA
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Golan Y, DuPont HL, Aldomiro F, Jensen EH, Hanson ME, Dorr MB. Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials. Open Forum Infect Dis. 2020 Jul; 7(7):ofaa248. PMID: 32685606.
      View in: PubMed
    2. DuPont HL, Jiang ZD, DuPont AW, Utay NS. Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation. Dig Dis Sci. 2020 03; 65(3):741-756. PMID: 32008133.
      View in: PubMed
    3. Chey WD, Shah ED, DuPont HL. Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review. Therap Adv Gastroenterol. 2020; 13:1756284819897531. PMID: 32047534.
      View in: PubMed
    4. Dupont HL, Jiang ZD, Dupont AW, Utay NS. THE INTESTINAL MICROBIOME IN HUMAN HEALTH AND DISEASE. Trans Am Clin Climatol Assoc. 2020; 131:178-197. PMID: 32675857.
      View in: PubMed
    5. Rashid T, Haghighi F, Hasan I, Bassères E, Alam MJ, Sharma SV, Lai D, DuPont HL, Garey KW. Activity of Hospital Disinfectants against Vegetative Cells and Spores of Clostridioides difficile Embedded in Biofilms. Antimicrob Agents Chemother. 2019 12 20; 64(1). PMID: 31611365.
      View in: PubMed
    6. Steffen R, DuPont HL. Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers' diarrhoea: reply. J Travel Med. 2019 05 10; 26(3). PMID: 30848824.
      View in: PubMed
    7. Darkoh C, Plants-Paris K, Bishoff D, DuPont HL. Clostridium difficile Modulates the Gut Microbiota by Inducing the Production of Indole, an Interkingdom Signaling and Antimicrobial Molecule. mSystems. 2019 Mar-Apr; 4(2). PMID: 30944877.
      View in: PubMed
    8. Bamidele O, Jiang ZD, Dupont H. Occurrence of putative virulence-related genes, aatA, aggR and aaiC, of Enteroaggregative Escherichia coli (EAEC) among adults with travelers' diarrhea acquired in Guatemala and Mexico. Microb Pathog. 2019 Mar; 128:97-99. PMID: 30579944.
      View in: PubMed
    9. Lindsay L, DuPont HL, Moe CL, Alberer M, Hatz C, Kirby AE, Wu HM, Verstraeten T, Steffen R. Estimating the incidence of norovirus acute gastroenteritis among US and European international travelers to areas of moderate to high risk of traveler's diarrhea: a prospective cohort study protocol. BMC Infect Dis. 2018 Dec 03; 18(1):605. PMID: 30509202.
      View in: PubMed
    10. Zhu Q, Dupont CL, Jones MB, Pham KM, Jiang ZD, DuPont HL, Highlander SK. Visualization-assisted binning of metagenome assemblies reveals potential new pathogenic profiles in idiopathic travelers' diarrhea. Microbiome. 2018 11 08; 6(1):201. PMID: 30409177.
      View in: PubMed
    11. Jiang ZD, Jenq RR, Ajami NJ, Petrosino JF, Alexander AA, Ke S, Iqbal T, DuPont AW, Muldrew K, Shi Y, Peterson C, Do KA, DuPont HL. Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial. PLoS One. 2018; 13(11):e0205064. PMID: 30388112.
      View in: PubMed
    12. Dogan B, Belcher-Timme HF, Dogan EI, Jiang ZD, DuPont HL, Snyder N, Yang S, Chandler B, Scherl EJ, Simpson KW. Evaluation of Escherichia coli pathotypes associated with irritable bowel syndrome. FEMS Microbiol Lett. 2018 11 01; 365(22). PMID: 30299475.
      View in: PubMed
    13. Valilis E, Ramsey A, Sidiq S, DuPont HL. Non-O157 Shiga toxin-producing Escherichia coli-A poorly appreciated enteric pathogen: Systematic review. Int J Infect Dis. 2018 Nov; 76:82-87. PMID: 30223088.
      View in: PubMed
    14. DuPont HL. Search for the optimal antimicrobial therapy of Clostridium difficile infection. Lancet Infect Dis. 2018 09; 18(9):936-937. PMID: 30025912.
      View in: PubMed
    15. Oyaro MO, Plants-Paris K, Bishoff D, Malonza P, Gontier CS, DuPont HL, Darkoh C. High rate of Clostridium difficile among young adults presenting with diarrhea at two hospitals in Kenya. Int J Infect Dis. 2018 Sep; 74:24-28. PMID: 29960098.
      View in: PubMed
    16. Bajaj JS, Barbara G, DuPont HL, Mearin F, Gasbarrini A, Tack J. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases. Dig Liver Dis. 2018 08; 50(8):741-749. PMID: 29807873.
      View in: PubMed
    17. DuPont HL. Gastric Acid and Enteric Infections: Souring on the Use of PPIs. Dig Dis Sci. 2018 04; 63(4):814-817. PMID: 29427223.
      View in: PubMed
    18. Steffen R, Jiang ZD, Gracias Garcia ML, Araujo P, Stiess M, Nacak T, Greinwald R, DuPont HL. Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria. J Travel Med. 2018 01 01; 25(1). PMID: 30462260.
      View in: PubMed
    19. Darkoh C, Odo C, DuPont HL. Erratum for Darkoh et al., "Accessory Gene Regulator-1 Locus Is Essential for Virulence and Pathogenesis of Clostridium difficile". mBio. 2017 10 31; 8(5). PMID: 29089433.
      View in: PubMed
    20. DuPont HL, Bajaj JS. Comment: Rifampin-Resistant Staphylococcus aureus Bacteremia in a Patient on Chronic Rifaximin. Ann Pharmacother. 2018 01; 52(1):94-95. PMID: 29068235.
      View in: PubMed
    21. Chao AW, Bhatti M, DuPont HL, Nataro JP, Carlin LG, Okhuysen PC. Clinical features and molecular epidemiology of diarrheagenic Escherichia coli pathotypes identified by fecal gastrointestinal multiplex nucleic acid amplification in patients with cancer and diarrhea. Diagn Microbiol Infect Dis. 2017 Nov; 89(3):235-240. PMID: 28931467.
      View in: PubMed
    22. Jiang ZD, Alexander A, Ke S, Valilis EM, Hu S, Li B, DuPont HL. Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI). Anaerobe. 2017 Dec; 48:110-114. PMID: 28801119.
      View in: PubMed
    23. Darkoh C, Deaton M, DuPont HL. Nonantimicrobial drug targets for Clostridium difficile infections. Future Microbiol. 2017 09; 12:975-985. PMID: 28759258.
      View in: PubMed
    24. Darkoh C, DuPont HL. The accessory gene regulator-1 as a therapeutic target for C. difficile infections. Expert Opin Ther Targets. 2017 05; 21(5):451-453. PMID: 28338356.
      View in: PubMed
    25. Riddle MS, Connor BA, Beeching NJ, DuPont HL, Hamer DH, Kozarsky P, Libman M, Steffen R, Taylor D, Tribble DR, Vila J, Zanger P, Ericsson CD. Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report. J Travel Med. 2017 Apr 01; 24(suppl_1):S57-S74. PMID: 28521004.
      View in: PubMed
    26. DuPont HL, Steffen R. Use of antimicrobial agents for treatment and prevention of travellers' diarrhoea in the face of enhanced risk of transient fecal carriage of multi-drug resistant enterobacteriaceae: setting the stage for consensus recommendations. J Travel Med. 2017 04 01; 24(suppl_1):S57-S62. PMID: 28881862.
      View in: PubMed
    27. Nicholson MR, Crews JD, Starke JR, Jiang ZD, DuPont H, Edwards K. Recurrent Clostridium difficile Infection in Children: Patient Risk Factors and Markers of Intestinal Inflammation. Pediatr Infect Dis J. 2017 04; 36(4):379-383. PMID: 27977555.
      View in: PubMed
    28. DuPont HL. Emerging Infectious Diseases, Animals, and Future Epidemics. Tex Med. 2017 Feb 01; 113(2):31-36. PMID: 28207078.
      View in: PubMed
    29. DuPont HL, Wolf RA, Israel RJ, Pimentel M. Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin. Antimicrob Agents Chemother. 2017 01; 61(1). PMID: 27795384.
      View in: PubMed
    30. Kharat VB, Ahmed M, Jiang ZD, Riddle MS, DuPont HL. Colonization Factors in Enterotoxigenic Escherichia coli Strains in Travelers to Mexico, Guatemala, and India Compared with Children in Houston, Texas. Am J Trop Med Hyg. 2017 Jan 11; 96(1):83-87. PMID: 28077742.
      View in: PubMed
    31. Al-Jashaami LS, DuPont HL. Management of Clostridium difficile Infection. Gastroenterol Hepatol (N Y). 2016 Oct; 12(10):609-616. PMID: 27917075.
      View in: PubMed
    32. Garey KW, Aitken SL, Gschwind L, Goddu S, Xie Y, Duff C, Barbut F, Shah DN, DuPont HL. Development and Validation of a Clostridium difficile Health-related Quality-of-Life Questionnaire. J Clin Gastroenterol. 2016 09; 50(8):631-7. PMID: 26796081.
      View in: PubMed
    33. Darkoh C, Odo C, DuPont HL. Accessory Gene Regulator-1 Locus Is Essential for Virulence and Pathogenesis of Clostridium difficile. mBio. 2016 08 16; 7(4). PMID: 27531912.
      View in: PubMed
    34. DuPont HL, Steffen R. Use of antimicrobial agents for treatment and prevention of travellers' diarrhoea in the face of enhanced risk of transient fecal carriage of multi-drug resistant enterobacteriaceae: setting the stage for consensus recommendations. J Travel Med. 2016 06; 23(6). PMID: 27503854.
      View in: PubMed
    35. DuPont HL. Persistent Diarrhea: A Clinical Review. JAMA. 2016 Jun 28; 315(24):2712-23. PMID: 27357241.
      View in: PubMed
    36. Riddle MS, DuPont HL, Connor BA. ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. Am J Gastroenterol. 2016 05; 111(5):602-22. PMID: 27068718.
      View in: PubMed
    37. DuPont HL. Therapeutic Effects and Mechanisms of Action of Rifaximin in Gastrointestinal Diseases. Mayo Clin Proc. 2015 Aug; 90(8):1116-24. PMID: 26162610.
      View in: PubMed
    38. Patel R, DuPont HL. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis. 2015 May 15; 60 Suppl 2:S108-21. PMID: 25922396.
      View in: PubMed
    39. Darkoh C, DuPont HL, Norris SJ, Kaplan HB. Toxin synthesis by Clostridium difficile is regulated through quorum signaling. mBio. 2015 Feb 24; 6(2):e02569. PMID: 25714717.
      View in: PubMed
    40. Chertow DS, Uyeki TM, DuPont HL. Loperamide therapy for voluminous diarrhea in Ebola virus disease. J Infect Dis. 2015 Apr 01; 211(7):1036-7. PMID: 25573887.
      View in: PubMed
    41. Steffen R, Hill DR, DuPont HL. Traveler's diarrhea: a clinical review. JAMA. 2015 Jan 06; 313(1):71-80. PMID: 25562268.
      View in: PubMed
    42. Steffen R, Hill DR, DuPont HL. JAMA patient page. Traveler's diarrhea. JAMA. 2015 Jan 06; 313(1):108. PMID: 25562284.
      View in: PubMed
    43. Youmans BP, Ajami NJ, Jiang ZD, Campbell F, Wadsworth WD, Petrosino JF, DuPont HL, Highlander SK. Characterization of the human gut microbiome during travelers' diarrhea. Gut Microbes. 2015; 6(2):110-9. PMID: 25695334.
      View in: PubMed
    44. DuPont HL, Petersen A, Zhao J, Mundt A, Jiang ZD, Miller S, Flores J, Shringarpure R, Moro L, Bagin RG, Ballard ED, Totoritis MC. Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study. J Travel Med. 2014 Nov-Dec; 21(6):369-76. PMID: 25345982.
      View in: PubMed
    45. Crews JD, Koo HL, Jiang ZD, Starke JR, DuPont HL. A hospital-based study of the clinical characteristics of Clostridium difficile infection in children. Pediatr Infect Dis J. 2014 Sep; 33(9):924-8. PMID: 25361022.
      View in: PubMed
    46. Aitken SL, Joseph TB, Shah DN, Lasco TM, Palmer HR, DuPont HL, Xie Y, Garey KW. Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas. PLoS One. 2014; 9(7):e102848. PMID: 25057871.
      View in: PubMed
    47. DuPont HL. Challenges and opportunities in the management of Clostridium difficile infection. Expert Rev Gastroenterol Hepatol. 2014 Nov; 8(8):863-74. PMID: 25012255.
      View in: PubMed
    48. DuPont HL. Chemoprophylaxis of Clostridium difficile infections in high-risk hospitalized patients. Clin Gastroenterol Hepatol. 2014 Nov; 12(11):1862-4. PMID: 24768812.
      View in: PubMed
    49. Koo HL, Van JN, Zhao M, Ye X, Revell PA, Jiang ZD, Grimes CZ, Koo DC, Lasco T, Kozinetz CA, Garey KW, DuPont HL. Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates. Infect Control Hosp Epidemiol. 2014 Jun; 35(6):667-73. PMID: 24799643.
      View in: PubMed
    50. DuPont HL. Acute infectious diarrhea in immunocompetent adults. N Engl J Med. 2014 Apr 17; 370(16):1532-40. PMID: 24738670.
      View in: PubMed
    51. Darkoh C, Comer L, Zewdie G, Harold S, Snyder N, Dupont HL. Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome. PLoS One. 2014; 9(3):e93144. PMID: 24667736.
      View in: PubMed
    52. Nair P, Okhuysen PC, Jiang ZD, Carlin LG, Belkind-Gerson J, Flores J, Paredes M, DuPont HL. Persistent abdominal symptoms in US adults after short-term stay in Mexico. J Travel Med. 2014 May-Jun; 21(3):153-8. PMID: 24621006.
      View in: PubMed
    53. DuPont AW, Jiang ZD, Harold SA, Snyder N, Galler GW, Garcia-Torres F, DuPont HL. Motility abnormalities in irritable bowel syndrome. Digestion. 2014; 89(2):119-23. PMID: 24503633.
      View in: PubMed
    54. Darkoh C, Turnwald BP, Koo HL, Garey KW, Jiang ZD, Aitken SL, DuPont HL. Colonic immunopathogenesis of Clostridium difficile infections. Clin Vaccine Immunol. 2014 Apr; 21(4):509-17. PMID: 24477852.
      View in: PubMed
    55. Ajami NJ, Kavanagh OV, Ramani S, Crawford SE, Atmar RL, Jiang ZD, Okhuysen PC, Estes MK, DuPont HL. Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med. 2014 Jan-Feb; 21(1):6-11. PMID: 24383649.
      View in: PubMed
    56. Behrens RH, Cramer JP, Jelinek T, Shaw H, von Sonnenburg F, Wilbraham D, Weinke T, Bell DJ, Asturias E, Pauwells HL, Maxwell R, Paredes-Paredes M, Glenn GM, Dewasthaly S, Stablein DM, Jiang ZD, DuPont HL. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. Lancet Infect Dis. 2014 Mar; 14(3):197-204. PMID: 24291168.
      View in: PubMed
    57. Darkoh C, Brown EL, Kaplan HB, DuPont HL. Bile salt inhibition of host cell damage by Clostridium difficile toxins. PLoS One. 2013; 8(11):e79631. PMID: 24244530.
      View in: PubMed
    58. Youmans BP, Ajami NJ, Jiang ZD, Petrosino JF, DuPont HL, Highlander SK. Development and accuracy of quantitative real-time polymerase chain reaction assays for detection and quantification of enterotoxigenic Escherichia coli (ETEC) heat labile and heat stable toxin genes in travelers' diarrhea samples. Am J Trop Med Hyg. 2014 Jan; 90(1):124-32. PMID: 24189361.
      View in: PubMed
    59. Dupont HL. Chronic complications after travelers' diarrhea. J Travel Med. 2013 Sep-Oct; 20(5):273-4. PMID: 23992567.
      View in: PubMed
    60. Steffen R, Cramer JP, Burchard G, Jelinek T, Schwarz U, Ramdas P, Chatterjee S, Jiang ZD, DuPont HL, Dewasthaly S, Westritschnig K, Behrens RH. Efficacy of a travelers' diarrhea vaccine system in travelers to India. J Travel Med. 2013 Nov-Dec; 20(6):374-9. PMID: 24165382.
      View in: PubMed
    61. Schrodt C, McHugh EE, Gawinowicz MA, Dupont HL, Brown EL. Rifaximin-mediated changes to the epithelial cell proteome: 2-D gel analysis. PLoS One. 2013; 8(7):e68550. PMID: 23922656.
      View in: PubMed
    62. DuPont HL. Giardia: both a harmless commensal and a devastating pathogen. J Clin Invest. 2013 Jun; 123(6):2352-4. PMID: 23728170.
      View in: PubMed
    63. Huang JS, Jiang ZD, Garey KW, Lasco T, Dupont HL. Use of rifamycin drugs and development of infection by rifamycin-resistant strains of Clostridium difficile. Antimicrob Agents Chemother. 2013 Jun; 57(6):2690-3. PMID: 23545528.
      View in: PubMed
    64. Dupont HL. Diagnosis and management of Clostridium difficile infection. Clin Gastroenterol Hepatol. 2013 Oct; 11(10):1216-23; quiz e73. PMID: 23542332.
      View in: PubMed
    65. Dogan B, Scherl E, Bosworth B, Yantiss R, Altier C, McDonough PL, Jiang ZD, Dupont HL, Garneau P, Harel J, Rishniw M, Simpson KW. Multidrug resistance is common in Escherichia coli associated with ileal Crohn's disease. Inflamm Bowel Dis. 2013 Jan; 19(1):141-50. PMID: 22508665.
      View in: PubMed
    66. Jiang ZD, Hoang LN, Lasco TM, Garey KW, Dupont HL. Physician attitudes toward the use of fecal transplantation for recurrent Clostridium difficile infection in a metropolitan area. Clin Infect Dis. 2013 Apr; 56(7):1059-60. PMID: 23223589.
      View in: PubMed
    67. Kothary V, Scherl EJ, Bosworth B, Jiang ZD, Dupont HL, Harel J, Simpson KW, Dogan B. Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-ß-naphthylamide-inhibitable efflux pumps. Antimicrob Agents Chemother. 2013 Feb; 57(2):811-7. PMID: 23183443.
      View in: PubMed
    68. Koo HL, Neill FH, Estes MK, Munoz FM, Cameron A, DuPont HL, Atmar RL. Noroviruses: The Most Common Pediatric Viral Enteric Pathogen at a Large University Hospital After Introduction of Rotavirus Vaccination. J Pediatric Infect Dis Soc. 2013 Mar; 2(1):57-60. PMID: 23687584.
      View in: PubMed
    69. Khalaf N, Crews JD, DuPont HL, Koo HL. Clostridium difficile: an emerging pathogen in children. Discov Med. 2012 Aug; 14(75):105-13. PMID: 22935207.
      View in: PubMed
    70. Koo HL, Sabounchi S, Huang DB, DuPont HL. Rifaximin therapy of irritable bowel syndrome. Clin Med Insights Gastroenterol. 2012; 5:31-41. PMID: 24833932.
      View in: PubMed
    71. MacArthur RD, DuPont HL. Etiology and pharmacologic management of noninfectious diarrhea in HIV-infected individuals in the highly active antiretroviral therapy era. Clin Infect Dis. 2012 Sep; 55(6):860-7. PMID: 22700829.
      View in: PubMed
    72. Mora AL, Salazar M, Pablo-Caeiro J, Frost CP, Yadav Y, DuPont HL, Garey KW. Moderate to high use of opioid analgesics are associated with an increased risk of Clostridium difficile infection. Am J Med Sci. 2012 Apr; 343(4):277-80. PMID: 21934595.
      View in: PubMed
    73. Boyce JM, Dupont HL, Massaro J, Sack D, Schaffner DW. An expert panel report of a proposed scientific model demonstrating the effectiveness of antibacterial handwash products. Am J Infect Control. 2012 Oct; 40(8):742-9. PMID: 22300895.
      View in: PubMed
    74. Pfeiffer ML, DuPont HL, Ochoa TJ. The patient presenting with acute dysentery--a systematic review. J Infect. 2012 Apr; 64(4):374-86. PMID: 22266388.
      View in: PubMed
    75. DuPont HL. Approach to the patient with infectious colitis. Curr Opin Gastroenterol. 2012 Jan; 28(1):39-46. PMID: 22080825.
      View in: PubMed
    76. Zhu Q, Zou L, Jagavelu K, Simonetto DA, Huebert RC, Jiang ZD, DuPont HL, Shah VH. Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice. J Hepatol. 2012 Apr; 56(4):893-9. PMID: 22173161.
      View in: PubMed
    77. Darkoh C, Dupont HL, Kaplan HB. Novel one-step method for detection and isolation of active-toxin-producing Clostridium difficile strains directly from stool samples. J Clin Microbiol. 2011 Dec; 49(12):4219-24. PMID: 21976761.
      View in: PubMed
    78. Paredes-Paredes M, Flores-Figueroa J, Dupont HL. Advances in the treatment of travelers' diarrhea. Curr Gastroenterol Rep. 2011 Oct; 13(5):402-7. PMID: 21773708.
      View in: PubMed
    79. Dupont HL. Gastrointestinal infections and the development of irritable bowel syndrome. Curr Opin Infect Dis. 2011 Oct; 24(5):503-8. PMID: 21844806.
      View in: PubMed
    80. Garey KW, Ghantoji SS, Shah DN, Habib M, Arora V, Jiang ZD, DuPont HL. A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. J Antimicrob Chemother. 2011 Dec; 66(12):2850-5. PMID: 21948965.
      View in: PubMed
    81. DuPont AW, DuPont HL. The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol. 2011 Aug 16; 8(9):523-31. PMID: 21844910.
      View in: PubMed
    82. Flores-Figueroa J, Okhuysen PC, von Sonnenburg F, DuPont HL, Libman MD, Keystone JS, Hale DC, Burchard G, Han PV, Wilder-Smith A, Freedman DO. Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience. Clin Infect Dis. 2011 Sep; 53(6):523-31. PMID: 21832261.
      View in: PubMed
    83. Darkoh C, DuPont HL. Unraveling the role of host endocytic proteins in pedestal formation during enteropathogenic Escherichia coli infection. J Infect Dis. 2011 Sep 01; 204(5):667-8. PMID: 21810916.
      View in: PubMed
    84. Flores J, Dupont HL, Jiang ZD, Okhuysen PC, Melendez-Romero JH, Gonzalez-Estrada A, Carrillo I, Paredes M. A randomized, double-blind, pilot study of rifaximin 550 mg versus placebo in the prevention of travelers' diarrhea in Mexico during the dry season. J Travel Med. 2011 Sep-Oct; 18(5):333-6. PMID: 21896097.
      View in: PubMed
    85. Darkoh C, Kaplan HB, Dupont HL. Harnessing the glucosyltransferase activities of Clostridium difficile for functional studies of toxins A and B. J Clin Microbiol. 2011 Aug; 49(8):2933-41. PMID: 21653766.
      View in: PubMed
    86. Mohamed JA, DuPont HL, Flores J, Palur H, Nair P, Jiang ZD, Guo D, Belkind-Gerson J, Okhuysen PC. Single nucleotide polymorphisms in the promoter of the gene encoding the lipopolysaccharide receptor CD14 are associated with bacterial diarrhea in US and Canadian travelers to Mexico. Clin Infect Dis. 2011 Jun; 52(11):1332-41. PMID: 21596674.
      View in: PubMed
    87. Long KZ, Garcia C, Ko G, Santos JI, Al Mamun A, Rosado JL, DuPont HL, Nathakumar N. Vitamin A modifies the intestinal chemokine and cytokine responses to norovirus infection in Mexican children. J Nutr. 2011 May; 141(5):957-63. PMID: 21411606.
      View in: PubMed
    88. Paredes-Paredes M, Okhuysen PC, Flores J, Mohamed JA, Padda RS, Gonzalez-Estrada A, Haley CA, Carlin LG, Nair P, DuPont HL. Seasonality of diarrheagenic Escherichia coli pathotypes in the US students acquiring diarrhea in Mexico. J Travel Med. 2011 Mar-Apr; 18(2):121-5. PMID: 21366796.
      View in: PubMed
    89. DuPont HL. The search for effective treatment of Clostridium difficile infection. N Engl J Med. 2011 Feb 03; 364(5):473-5. PMID: 21288079.
      View in: PubMed
    90. DuPont HL. Biologic properties and clinical uses of rifaximin. Expert Opin Pharmacother. 2011 Feb; 12(2):293-302. PMID: 21226639.
      View in: PubMed
    91. de la Cabada Bauche J, Dupont HL. New Developments in Traveler's Diarrhea. Gastroenterol Hepatol (N Y). 2011 Feb; 7(2):88-95. PMID: 21475415.
      View in: PubMed
    92. Long KZ, Santos JI, Rosado JL, Estrada-Garcia T, Haas M, Al Mamun A, DuPont HL, Nanthakumar NN. Vitamin A supplementation modifies the association between mucosal innate and adaptive immune responses and resolution of enteric pathogen infections. Am J Clin Nutr. 2011 Mar; 93(3):578-85. PMID: 21248183.
      View in: PubMed
    93. Aboshady I, Cody DD, Johnson EM, Gahremanpour A, Vela D, Khalil KG, Dupont HL, Willerson JT, Buja LM, Gladish GW. Flat-panel versus 64-channel computed tomography for in vivo quantitative characterization of aortic atherosclerotic plaques. Int J Cardiol. 2012 May 03; 156(3):295-302. PMID: 21185613.
      View in: PubMed
    94. Ouyang-Latimer J, Jafri S, VanTassel A, Jiang ZD, Gurleen K, Rodriguez S, Nandy RK, Ramamurthy T, Chatterjee S, McKenzie R, Steffen R, DuPont HL. In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008. Antimicrob Agents Chemother. 2011 Feb; 55(2):874-8. PMID: 21115800.
      View in: PubMed
    95. Villa NA, Okhuysen PC, Flores-Figueroa J, Jiang ZD, Belkind-Gerson J, Paredes M, Mohamed JA, Nair P, Carlin L, DuPont HL. Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico. J Travel Med. 2011 Jan-Feb; 18(1):56-8. PMID: 21199144.
      View in: PubMed
    96. Garey KW, Jiang ZD, Ghantoji S, Tam VH, Arora V, Dupont HL. A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection. Clin Infect Dis. 2010 Dec 15; 51(12):1406-10. PMID: 21058913.
      View in: PubMed
    97. Okhuysen PC, Dupont HL. Enteroaggregative Escherichia coli (EAEC): a cause of acute and persistent diarrhea of worldwide importance. J Infect Dis. 2010 Aug 15; 202(4):503-5. PMID: 20594108.
      View in: PubMed
    98. Dupont HL, Garey KW. Clostridium difficile infection: an emerging epidemic with more questions than answers. Future Microbiol. 2010 Aug; 5(8):1153-6. PMID: 20722592.
      View in: PubMed
    99. Cottreau J, Baker SF, DuPont HL, Garey KW. Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections. Expert Rev Anti Infect Ther. 2010 Jul; 8(7):747-60. PMID: 20586560.
      View in: PubMed
    100. Koo HL, Garey KW, Dupont HL. Future novel therapeutic agents for Clostridium difficile infection. Expert Opin Investig Drugs. 2010 Jul; 19(7):825-36. PMID: 20521993.
      View in: PubMed
    101. Koo HL, Ajami N, Atmar RL, DuPont HL. Noroviruses: The leading cause of gastroenteritis worldwide. Discov Med. 2010 Jul; 10(50):61-70. PMID: 20670600.
      View in: PubMed
    102. Ouyang-Latimer J, Ajami NJ, Jiang ZD, Okhuysen PC, Paredes M, Flores J, Dupont HL. Biochemical and genetic diversity of enterotoxigenic Escherichia coli associated with diarrhea in United States students in Cuernavaca and Guadalajara, Mexico, 2004-2007. J Infect Dis. 2010 Jun 15; 201(12):1831-8. PMID: 20443738.
      View in: PubMed
    103. Darkoh C, Lichtenberger LM, Ajami N, Dial EJ, Jiang ZD, DuPont HL. Bile acids improve the antimicrobial effect of rifaximin. Antimicrob Agents Chemother. 2010 Sep; 54(9):3618-24. PMID: 20547807.
      View in: PubMed
    104. Long SG, DuPont HL, Gaul L, Arafat RR, Selwyn BJ, Rogers J, Casey E. Pulsed-field gel electrophoresis for Salmonella infection surveillance, Texas, USA, 2007. Emerg Infect Dis. 2010 Jun; 16(6):983-5. PMID: 20507752.
      View in: PubMed
    105. Shah D, Dang MD, Hasbun R, Koo HL, Jiang ZD, DuPont HL, Garey KW. Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance. Expert Rev Anti Infect Ther. 2010 May; 8(5):555-64. PMID: 20455684.
      View in: PubMed
    106. Koo HL, Ajami NJ, Jiang ZD, Neill FH, Atmar RL, Ericsson CD, Okhuysen PC, Taylor DN, Bourgeois AL, Steffen R, DuPont HL. Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico. J Clin Microbiol. 2010 May; 48(5):1673-6. PMID: 20305012.
      View in: PubMed
    107. Flores J, DuPont HL, Paredes-Paredes M, Aguirre-Garcia MM, Rojas A, Gonzalez A, Okhuysen PC. Pilot study of whole-blood gamma interferon response to the Vibrio cholerae toxin B subunit and resistance to enterotoxigenic Escherichia coli-associated diarrhea. Clin Vaccine Immunol. 2010 May; 17(5):879-81. PMID: 20219880.
      View in: PubMed
    108. Martinez-Sandoval F, Ericsson CD, Jiang ZD, Okhuysen PC, Romero JH, Hernandez N, Forbes WP, Shaw A, Bortey E, DuPont HL. Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico. J Travel Med. 2010 Mar-Apr; 17(2):111-7. PMID: 20412178.
      View in: PubMed
    109. Vigil KJ, Johnson JR, Johnston BD, Kontoyiannis DP, Mulanovich VE, Raad II, Dupont HL, Adachi JA. Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis. 2010 Feb 01; 50(3):374-80. PMID: 20038242.
      View in: PubMed
    110. DuPont HL, Galler G, Garcia-Torres F, Dupont AW, Greisinger A, Jiang ZD. Travel and travelers' diarrhea in patients with irritable bowel syndrome. Am J Trop Med Hyg. 2010 Feb; 82(2):301-5. PMID: 20134008.
      View in: PubMed
    111. Jiang ZD, Dupont HL, Brown EL, Nandy RK, Ramamurthy T, Sinha A, Ghosh S, Guin S, Gurleen K, Rodrigues S, Chen JJ, McKenzie R, Steffen R. Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species. J Clin Microbiol. 2010 Apr; 48(4):1417-9. PMID: 20107088.
      View in: PubMed
    112. Koo HL, DuPont HL. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol. 2010 Jan; 26(1):17-25. PMID: 19881343.
      View in: PubMed
    113. Jiang ZD, Ke S, Dupont HL. Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei. Int J Antimicrob Agents. 2010 Mar; 35(3):278-81. PMID: 20045287.
      View in: PubMed
    114. Long KZ, Rosado JL, Santos JI, Haas M, Al Mamun A, DuPont HL, Nanthakumar NN, Estrada-Garcia T. Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections. Infect Immun. 2010 Mar; 78(3):1221-8. PMID: 20038536.
      View in: PubMed
    115. Dupont HL. Traveling internationally: avoiding and treating travelers' diarrhea. Clin Gastroenterol Hepatol. 2010 Jun; 8(6):490-3; quiz e71. PMID: 19948246.
      View in: PubMed
    116. Koo HL, Dupont HL, Huang DB. The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea. Ther Clin Risk Manag. 2009; 5:841-8. PMID: 19898648.
      View in: PubMed
    117. Brown EL, Xue Q, Jiang ZD, Xu Y, Dupont HL. Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles. Antimicrob Agents Chemother. 2010 Jan; 54(1):388-96. PMID: 19858255.
      View in: PubMed
    118. DuPont HL. Clinical practice. Bacterial diarrhea. N Engl J Med. 2009 Oct 15; 361(16):1560-9. PMID: 19828533.
      View in: PubMed
    119. Koo HL, DuPont HL. Noroviruses as a potential cause of protracted and lethal disease in immunocompromised patients. Clin Infect Dis. 2009 Oct 01; 49(7):1069-71. PMID: 19705972.
      View in: PubMed
    120. Salazar M, Baskin L, Garey KW, DuPont HL. Clostridium difficile-related death rates in Texas 1999-2005. J Infect. 2009 Nov; 59(5):303-7. PMID: 19735673.
      View in: PubMed
    121. Chongsuvivatwong V, Chariyalertsak S, McNeil E, Aiyarak S, Hutamai S, Dupont HL, Jiang ZD, Kalambaheti T, Tonyong W, Thitiphuree S, Steffen R. Epidemiology of travelers' diarrhea in Thailand. J Travel Med. 2009 May-Jun; 16(3):179-85. PMID: 19538578.
      View in: PubMed
    122. Vigil KJ, Jiang ZD, Chen JJ, Palumbo KL, Galbadage T, Brown EL, Yiang J, Koo H, DuPont MW, Ericsson C, Adachi JA, DuPont HL. Coliform and Escherichia coli contamination of desserts served in public restaurants from Guadalajara, Mexico, and Houston, Texas. Am J Trop Med Hyg. 2009 Apr; 80(4):606-8. PMID: 19346385.
      View in: PubMed
    123. Koo HL, Ajami NJ, Jiang ZD, Dupont HL, Atmar RL, Lewis D, Byers P, Abraham P, Quijano RA, Musher DM, Young EJ. A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection. Clin Infect Dis. 2009 Apr 01; 48(7):e75-7. PMID: 19245344.
      View in: PubMed
    124. Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg. 2009 Apr; 80(4):609-14. PMID: 19346386.
      View in: PubMed
    125. DuPont HL, Ericsson CD, Farthing MJ, Gorbach S, Pickering LK, Rombo L, Steffen R, Weinke T. Expert review of the evidence base for self-therapy of travelers' diarrhea. J Travel Med. 2009 May-Jun; 16(3):161-71. PMID: 19538576.
      View in: PubMed
    126. DuPont HL, Ericsson CD, Farthing MJ, Gorbach S, Pickering LK, Rombo L, Steffen R, Weinke T. Expert review of the evidence base for prevention of travelers' diarrhea. J Travel Med. 2009 May-Jun; 16(3):149-60. PMID: 19538575.
      View in: PubMed
    127. Koo HL, Koo DC, Musher DM, DuPont HL. Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis. Clin Infect Dis. 2009 Mar 01; 48(5):598-605. PMID: 19191646.
      View in: PubMed
    128. Mohamed JA, DuPont HL, Jiang ZD, Flores J, Carlin LG, Belkind-Gerson J, Martinez-Sandoval FG, Guo D, White AC, Okhuysen PC. A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North American travelers to Mexico. J Infect Dis. 2009 Feb 15; 199(4):477-85. PMID: 19128145.
      View in: PubMed
    129. Jiang ZD, Dupont HL, La Rocco M, Garey KW. WITHDRAWN: In vitro activity of rifaximin and rifampin against clinical isolates of clostridium difficile in houston, texas. Anaerobe. 2009 Feb 15. PMID: 19223017.
      View in: PubMed
    130. Garey KW, Jiang ZD, Bellard A, Dupont HL. Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot study. J Clin Gastroenterol. 2009 Jan; 43(1):91-3. PMID: 18385603.
      View in: PubMed
    131. Galbadage T, Jiang ZD, DuPont HL. Improvement in detection of enterotoxigenic Escherichia coli in patients with travelers' diarrhea by increasing the number of E. coli colonies tested. Am J Trop Med Hyg. 2009 Jan; 80(1):20-3. PMID: 19141833.
      View in: PubMed
    132. Estrada-Garcia T, Lopez-Saucedo C, Thompson-Bonilla R, Abonce M, Lopez-Hernandez D, Santos JI, Rosado JL, DuPont HL, Long KZ. Association of diarrheagenic Escherichia coli Pathotypes with infection and diarrhea among Mexican children and association of atypical Enteropathogenic E. coli with acute diarrhea. J Clin Microbiol. 2009 Jan; 47(1):93-8. PMID: 19020055.
      View in: PubMed
    133. Daly WJ, DuPont HL. The controversial and short-lived early use of rehydration therapy for cholera. Clin Infect Dis. 2008 Nov 15; 47(10):1315-9. PMID: 18840081.
      View in: PubMed
    134. Meraz IM, Jiang ZD, Ericsson CD, Bourgeois AL, Steffen R, Taylor DN, Hernandez N, DuPont HL. Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study. J Travel Med. 2008 Nov-Dec; 15(6):412-8. PMID: 19090795.
      View in: PubMed
    135. DuPont HL, Garey K, Caeiro JP, Jiang ZD. New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control. Curr Opin Infect Dis. 2008 Oct; 21(5):500-7. PMID: 18725800.
      View in: PubMed
    136. Nair P, Mohamed JA, DuPont HL, Figueroa JF, Carlin LG, Jiang ZD, Belkind-Gerson J, Martinez-Sandoval FG, Okhuysen PC. Epidemiology of cryptosporidiosis in North American travelers to Mexico. Am J Trop Med Hyg. 2008 Aug; 79(2):210-4. PMID: 18689626.
      View in: PubMed
    137. Garey KW, Jiang ZD, Yadav Y, Mullins B, Wong K, Dupont HL. Peripartum Clostridium difficile infection: case series and review of the literature. Am J Obstet Gynecol. 2008 Oct; 199(4):332-7. PMID: 18639213.
      View in: PubMed
    138. Koo HL, Jiang ZD, Brown E, Garcia C, Qi H, Dupont HL. Coliform contamination of vegetables obtained from popular restaurants in Guadalajara, Mexico, and Houston, Texas. Clin Infect Dis. 2008 Jul 15; 47(2):218-21. PMID: 18540820.
      View in: PubMed
    139. Flores J, DuPont HL, Lee SA, Belkind-Gerson J, Paredes M, Mohamed JA, Armitige LY, Guo DC, Okhuysen PC. Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico. Clin Vaccine Immunol. 2008 Aug; 15(8):1194-8. PMID: 18579697.
      View in: PubMed
    140. Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, Okhuysen PC, Guerrero NH, Martinez-Sandoval FG, Meléndez-Romero JH, Jiang ZD, Asturias EJ, Halpern J, Torres OR, Hoffman AS, Villar CP, Kassem RN, Flyer DC, Andersen BH, Kazempour K, Breisch SA, Glenn GM. Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet. 2008 Jun 14; 371(9629):2019-25. PMID: 18554712.
      View in: PubMed
    141. Grimes KA, Mohamed JA, Dupont HL, Padda RS, Jiang ZD, Flores J, Belkind-Gerson J, Martinez-Sandoval FG, Okhuysen PC. PCR-based assay using occult blood detection cards for detection of diarrheagenic Escherichia coli in specimens from U.S. travelers to Mexico with acute diarrhea. J Clin Microbiol. 2008 Jul; 46(7):2227-30. PMID: 18480224.
      View in: PubMed
    142. Shen BO, Jiang ZD, Fazio VW, Remzi FH, Rodriguez L, Bennett AE, Lopez R, Queener E, Dupont HL. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol. 2008 Jul; 6(7):782-8. PMID: 18467184.
      View in: PubMed
    143. Flores J, DuPont HL, Jiang ZD, Belkind-Gerson J, Mohamed JA, Carlin LG, Padda RS, Paredes M, Martinez-Sandoval JF, Villa NA, Okhuysen PC. Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico. J Travel Med. 2008 May-Jun; 15(3):156-61. PMID: 18494692.
      View in: PubMed
    144. Garey KW, Salazar M, Shah D, Rodrigue R, DuPont HL. Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea. Ann Pharmacother. 2008 Jun; 42(6):827-35. PMID: 18430792.
      View in: PubMed
    145. Huang DB, Brown EL, DuPont HL, Cerf J, Carlin L, Flores J, Belkind-Gerson J, Nataro JP, Okhuysen PC. Seroprevalence of the enteroaggregative Escherichia coli virulence factor dispersin among USA travellers to Cuernavaca, Mexico: a pilot study. J Med Microbiol. 2008 Apr; 57(Pt 4):476-479. PMID: 18349368.
      View in: PubMed
    146. Marcos LA, Terashima A, Dupont HL, Gotuzzo E. Strongyloides hyperinfection syndrome: an emerging global infectious disease. Trans R Soc Trop Med Hyg. 2008 Apr; 102(4):314-8. PMID: 18321548.
      View in: PubMed
    147. DuPont HL. President's address: travel medicine and principles of safe travel. Trans Am Clin Climatol Assoc. 2008; 119:1-27. PMID: 18596858.
      View in: PubMed
    148. Garcia C, Samalvides F, Vidal M, Gotuzzo E, Dupont HL. Epidemiology of Clostridium difficile-associated diarrhea in a Peruvian tertiary care hospital. Am J Trop Med Hyg. 2007 Nov; 77(5):802-5. PMID: 17984329.
      View in: PubMed
    149. DuPont HL. The growing threat of foodborne bacterial enteropathogens of animal origin. Clin Infect Dis. 2007 Nov 15; 45(10):1353-61. PMID: 17968835.
      View in: PubMed
    150. Huang DB, Mohamed JA, Nataro JP, DuPont HL, Jiang ZD, Okhuysen PC. Virulence characteristics and the molecular epidemiology of enteroaggregative Escherichia coli isolates from travellers to developing countries. J Med Microbiol. 2007 Oct; 56(Pt 10):1386-1392. PMID: 17893178.
      View in: PubMed
    151. Long KZ, Rosado JL, Montoya Y, de Lourdes Solano M, Hertzmark E, DuPont HL, Santos JI. Effect of vitamin A and zinc supplementation on gastrointestinal parasitic infections among Mexican children. Pediatrics. 2007 Oct; 120(4):e846-55. PMID: 17908741.
      View in: PubMed
    152. Marcos LA, DuPont HL. Advances in defining etiology and new therapeutic approaches in acute diarrhea. J Infect. 2007 Nov; 55(5):385-93. PMID: 17825422.
      View in: PubMed
    153. Ericsson CD, DuPont HL, Okhuysen PC, Jiang ZD, DuPont MW. Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone. J Travel Med. 2007 Sep-Oct; 14(5):312-9. PMID: 17883462.
      View in: PubMed
    154. Long KZ, Garcia C, Santos JI, Rosado JL, Hertzmark E, Dupont HL, Ko G. Vitamin A supplementation has divergent effects on norovirus infections and clinical symptoms among Mexican children. J Infect Dis. 2007 Oct 01; 196(7):978-85. PMID: 17763317.
      View in: PubMed
    155. DuPont HL. Therapy for and prevention of traveler's diarrhea. Clin Infect Dis. 2007 Jul 15; 45 Suppl 1:S78-84. PMID: 17582576.
      View in: PubMed
    156. Jiang ZD, Garey KW, Price M, Graham G, Okhuysen P, Dao-Tran T, LaRocco M, DuPont HL. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea. Clin Gastroenterol Hepatol. 2007 Aug; 5(8):964-8. PMID: 17618838.
      View in: PubMed
    157. Hanauer SB, DuPont HL, Cooper KM, Laudadio C. Randomized, double-blind, placebo-controlled clinical trial of loperamide plus simethicone versus loperamide alone and simethicone alone in the treatment of acute diarrhea with gas-related abdominal discomfort. Curr Med Res Opin. 2007 May; 23(5):1033-43. PMID: 17519069.
      View in: PubMed
    158. Dupont HL, Jiang ZD, Belkind-Gerson J, Okhuysen PC, Ericsson CD, Ke S, Huang DB, Dupont MW, Adachi JA, De La Cabada FJ, Taylor DN, Jaini S, Martinez Sandoval F. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin Gastroenterol Hepatol. 2007 Apr; 5(4):451-6. PMID: 17382603.
      View in: PubMed
    159. Mohamed JA, DuPont HL, Jiang ZD, Belkind-Gerson J, Figueroa JF, Armitige LY, Tsai A, Nair P, Martinez-Sandoval FJ, Guo DC, Hayes P, Okhuysen PC. A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clin Infect Dis. 2007 Apr 01; 44(7):945-52. PMID: 17342646.
      View in: PubMed
    160. DuPont HL. Relearning the importance of disease prevention among international travelers. Am J Gastroenterol. 2007 Feb; 102(2):458-9; author reply 459-60. PMID: 17311662.
      View in: PubMed
    161. Long KZ, Rosado JL, DuPont HL, Hertzmark E, Santos JI. Supplementation with vitamin A reduces watery diarrhoea and respiratory infections in Mexican children. Br J Nutr. 2007 Feb; 97(2):337-43. PMID: 17298703.
      View in: PubMed
    162. DuPont HL, Haake R, Taylor DN, Ericsson CD, Jiang ZD, Okhuysen PC, Steffen R. Rifaximin treatment of pathogen-negative travelers' diarrhea. J Travel Med. 2007 Jan-Feb; 14(1):16-9. PMID: 17241249.
      View in: PubMed
    163. DuPont HL. Azithromycin for the self-treatment of traveler's diarrhea. Clin Infect Dis. 2007 Feb 01; 44(3):347-9. PMID: 17205439.
      View in: PubMed
    164. Hill DR, Ericsson CD, Pearson RD, Keystone JS, Freedman DO, Kozarsky PE, DuPont HL, Bia FJ, Fischer PR, Ryan ET. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006 Dec 15; 43(12):1499-539. PMID: 17109284.
      View in: PubMed
    165. Mohamed JA, Huang DB, Jiang ZD, DuPont HL, Nataro JP, Belkind-Gerson J, Okhuysen PC. Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries. J Clin Microbiol. 2007 Jan; 45(1):121-6. PMID: 17093030.
      View in: PubMed
    166. Cabada MM, Maldonado F, Quispe W, Mozo K, Serrano E, González E, Seas C, Verdonck K, Echevarria JI, Dupont HL, Gotuzzo E. Risk factors associated with diarrhea among international visitors to Cuzco, Peru. Am J Trop Med Hyg. 2006 Nov; 75(5):968-72. PMID: 17123998.
      View in: PubMed
    167. Turner SM, Chaudhuri RR, Jiang ZD, DuPont H, Gyles C, Penn CW, Pallen MJ, Henderson IR. Phylogenetic comparisons reveal multiple acquisitions of the toxin genes by enterotoxigenic Escherichia coli strains of different evolutionary lineages. J Clin Microbiol. 2006 Dec; 44(12):4528-36. PMID: 17050815.
      View in: PubMed
    168. Huang DB, Mohanty A, DuPont HL, Okhuysen PC, Chiang T. A review of an emerging enteric pathogen: enteroaggregative Escherichia coli. J Med Microbiol. 2006 Oct; 55(Pt 10):1303-1311. PMID: 17005776.
      View in: PubMed
    169. Long KZ, Santos JI, Estrada Garcia T, Haas M, Firestone M, Bhagwat J, Dupont HL, Hertzmark E, Rosado JL, Nanthakumar NN. Vitamin A supplementation reduces the monocyte chemoattractant protein-1 intestinal immune response of Mexican children. J Nutr. 2006 Oct; 136(10):2600-5. PMID: 16988133.
      View in: PubMed
    170. Long KZ, Santos JI, Rosado JL, Lopez-Saucedo C, Thompson-Bonilla R, Abonce M, DuPont HL, Hertzmark E, Estrada-Garcia T. Impact of vitamin A on selected gastrointestinal pathogen infections and associated diarrheal episodes among children in Mexico City, Mexico. J Infect Dis. 2006 Nov 01; 194(9):1217-25. PMID: 17041847.
      View in: PubMed
    171. García C, DuPont HL, Long KZ, Santos JI, Ko G. Asymptomatic norovirus infection in Mexican children. J Clin Microbiol. 2006 Aug; 44(8):2997-3000. PMID: 16891526.
      View in: PubMed
    172. Huang DB, Nataro JP, DuPont HL, Kamat PP, Mhatre AD, Okhuysen PC, Chiang T. Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis. Clin Infect Dis. 2006 Sep 01; 43(5):556-63. PMID: 16886146.
      View in: PubMed
    173. Musher DM, Logan N, Hamill RJ, Dupont HL, Lentnek A, Gupta A, Rossignol JF. Nitazoxanide for the treatment of Clostridium difficile colitis. Clin Infect Dis. 2006 Aug 15; 43(4):421-7. PMID: 16838229.
      View in: PubMed
    174. Pacheco-Gil L, Ochoa TJ, Flores-Romo L, DuPont HL, Estrada-Garcia T. Enteroinvasive Escherichia coli severe dysentery complicated by rotavirus gastroenteritis. J Infect. 2006 Nov; 53(5):e211-3. PMID: 16769121.
      View in: PubMed
    175. Ko G, Jiang ZD, Okhuysen PC, DuPont HL. Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to Noroviruses. J Med Virol. 2006 Jun; 78(6):825-8. PMID: 16628572.
      View in: PubMed
    176. DuPont HL. New insights and directions in travelers' diarrhea. Gastroenterol Clin North Am. 2006 Jun; 35(2):337-53, viii-ix. PMID: 16880069.
      View in: PubMed
    177. Koo HL, DuPont HL. Current and future developments in travelers' diarrhea therapy. Expert Rev Anti Infect Ther. 2006 Jun; 4(3):417-27. PMID: 16771619.
      View in: PubMed
    178. Taylor DN, Bourgeois AL, Ericsson CD, Steffen R, Jiang ZD, Halpern J, Haake R, Dupont HL. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. Am J Trop Med Hyg. 2006 Jun; 74(6):1060-6. PMID: 16760520.
      View in: PubMed
    179. Garey KW, Graham G, Gerard L, Dao T, Jiang ZD, Price M, Dupont HL. Prevalence of diarrhea at a university hospital and association with modifiable risk factors. Ann Pharmacother. 2006 Jun; 40(6):1030-4. PMID: 16684806.
      View in: PubMed
    180. Long KZ, Estrada-Garcia T, Rosado JL, Ignacio Santos J, Haas M, Firestone M, Bhagwat J, Young C, DuPont HL, Hertzmark E, Nanthakumar NN. The effect of vitamin A supplementation on the intestinal immune response in Mexican children is modified by pathogen infections and diarrhea. J Nutr. 2006 May; 136(5):1365-70. PMID: 16614431.
      View in: PubMed
    181. Jiang ZD, DuPont HL, Garey K, Price M, Graham G, Okhuysen P, Dao-Tran T, LaRocco M. A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea. Am J Gastroenterol. 2006 May; 101(5):1112-6. PMID: 16573784.
      View in: PubMed
    182. Bundy JK, Gonzalez VR, Barnard BM, Hardy RJ, DuPont HL. Gender risk differences for surgical site infections among a primary coronary artery bypass graft surgery cohort: 1995-1998. Am J Infect Control. 2006 Apr; 34(3):114-21. PMID: 16630973.
      View in: PubMed
    183. DuPont AW, DuPont HL. Travelers' diarrhea: modern concepts and new developments. Curr Treat Options Gastroenterol. 2006 Feb; 9(1):13-21. PMID: 16423310.
      View in: PubMed
    184. Adachi JA, DuPont HL. Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders. Clin Infect Dis. 2006 Feb 15; 42(4):541-7. PMID: 16421799.
      View in: PubMed
    185. DuPont HL. Travellers' diarrhoea: contemporary approaches to therapy and prevention. Drugs. 2006; 66(3):303-14. PMID: 16526819.
      View in: PubMed
    186. Ko G, Garcia C, Jiang ZD, Okhuysen PC, Belkind-Gerson J, Glass RI, DuPont HL. Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico. J Clin Microbiol. 2005 Dec; 43(12):6126-9. PMID: 16333110.
      View in: PubMed
    187. DuPont HL, Jiang ZD, Okhuysen PC, Ericsson CD, de la Cabada FJ, Ke S, DuPont MW, Martinez-Sandoval F. Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin. Clin Infect Dis. 2005 Dec 01; 41 Suppl 8:S571-6. PMID: 16267721.
      View in: PubMed
    188. DuPont HL. What's new in enteric infectious diseases at home and abroad. Curr Opin Infect Dis. 2005 Oct; 18(5):407-12. PMID: 16148527.
      View in: PubMed
    189. Estrada-García T, Cerna JF, Paheco-Gil L, Velázquez RF, Ochoa TJ, Torres J, DuPont HL. Drug-resistant diarrheogenic Escherichia coli, Mexico. Emerg Infect Dis. 2005 Aug; 11(8):1306-8. PMID: 16102327.
      View in: PubMed
    190. Huang DB, DuPont HL. Problem pathogens: extra-intestinal complications of Salmonella enterica serotype Typhi infection. Lancet Infect Dis. 2005 Jun; 5(6):341-8. PMID: 15919620.
      View in: PubMed
    191. DuPont HL, Jiang ZD, Okhuysen PC, Ericsson CD, de la Cabada FJ, Ke S, DuPont MW, Martinez-Sandoval F. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med. 2005 May 17; 142(10):805-12. PMID: 15897530.
      View in: PubMed
    192. DuPont HL. Travelers' diarrhea: antimicrobial therapy and chemoprevention. Nat Clin Pract Gastroenterol Hepatol. 2005 Apr; 2(4):191-8; quiz 1 p following 198. PMID: 16265184.
      View in: PubMed
    193. Gerard L, Garey KW, DuPont HL. Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections. Expert Rev Anti Infect Ther. 2005 Apr; 3(2):201-11. PMID: 15918778.
      View in: PubMed
    194. Huang DB, DuPont HL. Rifaximin--a novel antimicrobial for enteric infections. J Infect. 2005 Feb; 50(2):97-106. PMID: 15667909.
      View in: PubMed
    195. Ericsson CD, DuPont HL. Rifaximin in the treatment of infectious diarrhea. Chemotherapy. 2005; 51 Suppl 1:73-80. PMID: 15855750.
      View in: PubMed
    196. Huang DB, Dupont HL. Enteroaggregative Escherichia coli: an emerging pathogen in children. Semin Pediatr Infect Dis. 2004 Oct; 15(4):266-71. PMID: 15494951.
      View in: PubMed
    197. Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol. 2004 Sep; 99(9):1774-8. PMID: 15330917.
      View in: PubMed
    198. Huang DB, Awasthi M, Le BM, Leve ME, DuPont MW, DuPont HL, Ericsson CD. The role of diet in the treatment of travelers' diarrhea: a pilot study. Clin Infect Dis. 2004 Aug 15; 39(4):468-71. PMID: 15356807.
      View in: PubMed
    199. Steffen R, Tornieporth N, Clemens SA, Chatterjee S, Cavalcanti AM, Collard F, De Clercq N, DuPont HL, von Sonnenburg F. Epidemiology of travelers' diarrhea: details of a global survey. J Travel Med. 2004 Jul-Aug; 11(4):231-7. PMID: 15541226.
      View in: PubMed
    200. Huang DB, DuPont HL, Jiang ZD, Carlin L, Okhuysen PC. Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli. Clin Diagn Lab Immunol. 2004 May; 11(3):548-51. PMID: 15138180.
      View in: PubMed
    201. Huang DB, Sanchez AP, Triana E, Jiang ZD, DuPont HL, Ericsson CD. United States male students who heavily consume alcohol in Mexico are at greater risk of travelers' diarrhea than their female counterparts. J Travel Med. 2004 May-Jun; 11(3):143-5. PMID: 15710056.
      View in: PubMed
    202. Huang DB, Koo H, DuPont HL. Enteroaggregative Escherichia coli: An Emerging Pathogen. Curr Infect Dis Rep. 2004 Apr; 6(2):83-86. PMID: 15023269.
      View in: PubMed
    203. Infante RM, Ericsson CD, Jiang ZD, Ke S, Steffen R, Riopel L, Sack DA, DuPont HL. Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy. Clin Gastroenterol Hepatol. 2004 Feb; 2(2):135-8. PMID: 15017618.
      View in: PubMed
    204. Huang DB, Okhuysen PC, Jiang ZD, DuPont HL. Enteroaggregative Escherichia coli: an emerging enteric pathogen. Am J Gastroenterol. 2004 Feb; 99(2):383-9. PMID: 15046233.
      View in: PubMed
    205. Huang DB, Jiang ZD, Dupont HL. Association of virulence factor-positive and -negative enteroaggregative Escherichia coli and occurrence of clinical illness in travelers from the United States to Mexico. Am J Trop Med Hyg. 2003 Nov; 69(5):506-8. PMID: 14695087.
      View in: PubMed
    206. Adachi JA, Ericsson CD, Jiang ZD, DuPont MW, Martinez-Sandoval F, Knirsch C, DuPont HL. Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clin Infect Dis. 2003 Nov 01; 37(9):1165-71. PMID: 14557959.
      View in: PubMed
    207. Horvath LL, Murray CK, DuPont HL. Travel health information at commercial travel websites. J Travel Med. 2003 Sep-Oct; 10(5):272-8. PMID: 14531980.
      View in: PubMed
    208. Jiang ZD, Okhuysen PC, Guo DC, He R, King TM, DuPont HL, Milewicz DM. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis. 2003 Aug 15; 188(4):506-11. PMID: 12898436.
      View in: PubMed
    209. Steffen R, Sack DA, Riopel L, Jiang ZD, Stürchler M, Ericsson CD, Lowe B, Waiyaki P, White M, DuPont HL. Therapy of travelers' diarrhea with rifaximin on various continents. Am J Gastroenterol. 2003 May; 98(5):1073-8. PMID: 12809830.
      View in: PubMed
    210. Jiang ZD, Greenberg D, Nataro JP, Steffen R, DuPont HL. Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers. J Clin Microbiol. 2002 Nov; 40(11):4185-90. PMID: 12409395.
      View in: PubMed
    211. DiCesare D, DuPont HL, Mathewson JJ, Ashley D, Martinez-Sandoval F, Pennington JE, Porter SB. A double blind, randomized, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Jamaica and Mexico. Am J Gastroenterol. 2002 Oct; 97(10):2585-8. PMID: 12385443.
      View in: PubMed
    212. Miqdady MS, Jiang ZD, Nataro JP, DuPont HL. Detection of enteroaggregative Escherichia coli with formalin-preserved HEp-2 cells. J Clin Microbiol. 2002 Aug; 40(8):3066-7. PMID: 12149382.
      View in: PubMed
    213. Adachi JA, Mathewson JJ, Jiang ZD, Ericsson CD, DuPont HL. Enteric pathogens in Mexican sauces of popular restaurants in Guadalajara, Mexico, and Houston, Texas. Ann Intern Med. 2002 Jun 18; 136(12):884-7. PMID: 12069562.
      View in: PubMed
    214. Adachi JA, Ericsson CD, Jiang ZD, DuPont MW, Pallegar SR, DuPont HL. Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico. J Infect Dis. 2002 Jun 01; 185(11):1681-3. PMID: 12023779.
      View in: PubMed
    215. Bouckenooghe AR, Jiang ZD, De La Cabada FJ, Ericsson CD, DuPont HL. Enterotoxigenic Escherichia coli as cause of diarrhea among Mexican adults and US travelers in Mexico. J Travel Med. 2002 May-Jun; 9(3):137-40. PMID: 12088579.
      View in: PubMed
    216. Greenberg DE, Jiang ZD, Steffen R, Verenker MP, DuPont HL. Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity. J Infect Dis. 2002 Apr 01; 185(7):944-9. PMID: 11920319.
      View in: PubMed
    217. Manatsathit S, Dupont HL, Farthing M, Kositchaiwat C, Leelakusolvong S, Ramakrishna BS, Sabra A, Speelman P, Surangsrirat S. Guideline for the management of acute diarrhea in adults. J Gastroenterol Hepatol. 2002 Feb; 17 Suppl:S54-71. PMID: 12000594.
      View in: PubMed
    218. Jiang ZD, Lowe B, Verenkar MP, Ashley D, Steffen R, Tornieporth N, von Sonnenburg F, Waiyaki P, DuPont HL. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis. 2002 Feb 15; 185(4):497-502. PMID: 11865402.
      View in: PubMed
    219. DuPont HL. Memorial. Major General Robert E. Blount 1908-2000. Trans Am Clin Climatol Assoc. 2002; 113:xlviii-l. PMID: 12053725.
      View in: PubMed
    220. DuPont HL, Lehan P. Memorial. Harper K. Hellems, M.D. 1920-1999. Trans Am Clin Climatol Assoc. 2002; 113:liv-lvi. PMID: 12053723.
      View in: PubMed
    221. DuPont HL. Travellers' diarrhoea. Which antimicrobial? Drugs. 1993 Jun; 45(6):910-917. PMID: 7691498.
      View in: PubMed
    DUPONT's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description